Search Results - "Bittar, Christina"

Refine Results
  1. 1
  2. 2
  3. 3

    DNA damage in blood leukocytes of individuals with sickle cell disease treated with hydroxyurea by Friedrisch, João Ricardo, Prá, Daniel, Maluf, Sharbel Weidner, Bittar, Christina Matzembacher, Mergener, Michelle, Pollo, Tiago, Kayser, Michele, da Silva, Maria Aparecida Lima, Henriques, João Antonio Pêgas, da Rocha Silla, Lucia Mariano

    Published in Mutation research (08-01-2008)
    “…Hydroxyurea (HU) plays an important role in the treatment of patients with sickle cell disease (SCD). Although HU has been associated with an increased risk of…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Effect of caffeine supplementation on haematological and biochemical variables in elite soccer players under physical stress conditions by Bassini-Cameron, Adriana, Sweet, Eric, Bottino, Altamiro, Bittar, Christina, Veiga, Carlos, Cameron, Luiz-Claudio

    Published in British journal of sports medicine (01-08-2007)
    “…Objective: To evaluate the effect of caffeine on white cell distribution and muscle injury markers in professional soccer players during exercise. Methods: 22…”
    Get full text
    Journal Article
  9. 9

    The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia by Alegretti, Ana Paula, Bittar, Christina Matzenbacher, Bittencourt, Rosane, Piccoli, Amanda Kirchner, Schneider, Laiana, Silla, Lúcia Mariano, Bó, Suzane Dal, Xavier, Ricardo Machado

    “…The expression of CD56 is considered a bad prognostic factor for overall survival, lower rates or short complete remission and extramedullary invasion but the…”
    Get full text
    Journal Article
  10. 10

    Genomic Instability in Sickle Cell Disease Patients Using Hydroxyurea Assessed by Micronucleus Assay by Friedrisch, Joao R., Maluf, Sharbel W., Bittar, Christina M., Silva, Maria A., Silla, Lucia M.

    Published in Blood (16-11-2006)
    “…Hydroxyurea (HU) is an antineoplastic drug, which also plays an important role in treatment of sickle cell disease patients (SCD). Short-term HU toxicities…”
    Get full text
    Journal Article
  11. 11
  12. 12

    High Prevalence of Anemia in Children and Adult Women in an Urban Population in Southern Brazil. e68805 by Silla, Mariano daRocha, Zelmanowicz, Alice, Mito, Ingrid, Michalowski, Mariana, Hellwing, Tania, Shilling, Marco Antonio, Friedrisch, Joao Ricardo, Bittar, Christina M, Albrecht, Cristina ArthmarMentz, Scapinello, Elaine

    Published in PloS one (01-07-2013)
    “…This population-based study was designed to detect the prevalence of anemia in a healthy population of children (18 months to 7 years) and women (14 to 30…”
    Get full text
    Journal Article
  13. 13

    Length of treatment and dose as determinants of mutagenicity in sickle cell disease patients treated with hydroxyurea by Maluf, Sharbel, Prá, Daniel, Friedrisch, João R, Bittar, Christina, da Silva, Maria A. Lima, Henriques, João A, Silla, Lucia

    Published in Environmental toxicology and pharmacology (01-01-2009)
    “…Abstract Hydroxyurea (HU) is an antineoplastic drug widely used in the clinical management of patients with sickle cell disease (SCD), and many questions…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Leucemia mielomonocítica juvenil: relato de caso by Farias, Mariela G., Lucena, Natália P., Bó, Suzane D., Bittar, Christina M., Castro Júnior, Cláudio G., Gregianin, Lauro J., Brunetto, Algemir L.

    “…A leucemia mielomonocítica juvenil (LMMJ) é uma doença rara, que representa de 2%a 3% de todas as leucemias pediátricas. É uma doença clonal de células da…”
    Get full text
    Journal Article
  18. 18

    Prevalência de talassemias e hemoglobinas variantes em pacientes com anemia não ferropênica by Wagner, Sandrine C., Silvestri, Matheus C., Bittar, Christina M., Friedrisch, João R., Silla, Lúcia M. R.

    “…Para estabelecer a freqüência de hemoglobinopatias e talassemias em pacientes com anemia não ferropênica foram estudados 58 casos de pacientes comprovadamente…”
    Get full text
    Journal Article
  19. 19

    Leucemia mielomonocítica juvenil: relato de caso Juvenile myelomonocytic leukaemia: case report by Mariela G. Farias, Natália P. Lucena, Suzane D. Bó, Christina M. Bittar, Cláudio G. Castro Júnior, Lauro J. Gregianin, Algemir L. Brunetto

    “…A leucemia mielomonocítica juvenil (LMMJ) é uma doença rara, que representa de 2%a 3% de todas as leucemias pediátricas. É uma doença clonal de células da…”
    Get full text
    Journal Article
  20. 20

    Prevalência de talassemias e hemoglobinas variantes em pacientes com anemia não ferropênica Prevalence of thalassemias and variant hemoglobins in patients with non-ferropenic anemia by Sandrine C. Wagner, Matheus C. Silvestri, Christina M. Bittar, João R. Friedrisch, Lúcia M. R. Silla

    “…Para estabelecer a freqüência de hemoglobinopatias e talassemias em pacientes com anemia não ferropênica foram estudados 58 casos de pacientes comprovadamente…”
    Get full text
    Journal Article